Alnylam Pharmaceuticals, Inc. (ALNY)

339.19 -0.18 (-0.05%) USD  |  NASDAQ  |  Feb 20, 12:23
More

Alnylam Pharmaceuticals Tobin's Q (Approximate) (Quarterly)

Tobin's Q (Approximate) (Quarterly) Chart

View Tobin's Q (Approximate) (Quarterly) for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Tobin's Q (Approximate) (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Tobin's Q (Approximate) (Quarterly) Range, Past 5 Years

View Tobin's Q (Approximate) (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Tobin's Q (Approximate) (Quarterly) Benchmarks

View Tobin's Q (Approximate) (Quarterly) Benchmarks
Start Trial
Insmed, Inc. Upgrade
Biogen, Inc. Upgrade
Pfizer Inc. Upgrade
Eli Lilly & Co. Upgrade
AbbVie, Inc. Upgrade